NRC Health Common Stock
NRC
96 hedge funds and large institutions have $464M invested in NRC Health Common Stock in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 11 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 34
0.98% more ownership
Funds ownership: 39.76% → 40.73% (+0.98%)
7% less funds holding
Funds holding: 103 → 96 (-7)
29% less capital invested
Capital invested by funds: $654M → $464M (-$189M)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.44M |
| 2 |
Comerica Bank
Dallas,
Texas
|
+$3.38M |
| 3 |
JP Morgan Chase
New York
|
+$3.32M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$3.2M |
| 5 |
Renaissance Technologies
New York
|
+$2.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.35M |
| 2 |
Morgan Stanley
New York
|
-$2.07M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.41M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$838K |
NRC Hedge Fund Activity: Q1 2020 in Review
96 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q1 2020, worth a combined $464M — down 29% from $654M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of NRC and 6 opened new positions — a net loss of 5 holders — while 34 trimmed existing stakes and 41 added.
The largest buyer was Ameriprise, adding an estimated $6.44M. The largest seller was Panagora Asset Management, cutting an estimated $2.35M.
- 96 institutional investors held NRC Health Common Stock (NRC) as of Q1 2020, down from 103 in Q4 2019.
- Funds reported $464M of NRC Health Common Stock stock for Q1 2020, down 29% quarter-over-quarter.
- 6 funds opened new NRC Health Common Stock positions in Q1 2020 and 11 closed out, a net change of -5 holders.
- The largest NRC Health Common Stock buyer in Q1 2020 was Ameriprise, an estimated $6.44M added.
- The largest NRC Health Common Stock seller in Q1 2020 was Panagora Asset Management, an estimated $2.35M sold.
Based on aggregated 13F filings for Q1 2020.